Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis

J. Prakash, M. Sandovici, V. Saluja, M. Lacombe, R.Q.J. Schaapveld, M.H. de Borst, H. van Goor, R.H. Henning, J.H. Proost, F. Moolenaar, G. Keri, D.F.K. Meijer, K. Poelstra, R.J. Kok

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1-12
Number of pages12
JournalJournal of Pharmacology and Experimental Therapeutics
Volume319
Publication statusPublished - 2006

Keywords

  • Medical technology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Pharmacology

Cite this